Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation

Exp Mol Med. 2017 Sep 8;49(9):e375. doi: 10.1038/emm.2017.132.

Abstract

Th17 cells promote inflammatory reactions, whereas regulatory T (Treg) cells inhibit them. Thus, the Th17/Treg cell balance is critically important in inflammatory diseases. However, the molecular mechanisms underlying this balance are unclear. Here, we demonstrate that casein kinase 2 (CK2) is a critical determinant of the Th17/Treg cell balance. Both the inhibition of CK2 with a specific pharmacological inhibitor, CX-4945, and its small hairpin RNA (shRNA)-mediated knockdown suppressed Th17 cell differentiation but reciprocally induced Treg cell differentiation in vitro. Moreover, CX-4945 ameliorated the symptoms of experimental autoimmune encephalomyelitis and reduced Th17 cell infiltration into the central nervous system. Mechanistically, CX-4945 inhibited the IL-6/STAT3 and Akt/mTOR signaling pathways. Thus, CK2 has a crucial role in regulating the Th17/Treg balance.

MeSH terms

  • Animals
  • Casein Kinase II / antagonists & inhibitors
  • Casein Kinase II / genetics
  • Casein Kinase II / metabolism*
  • Cell Differentiation* / genetics
  • Cell Differentiation* / immunology
  • Encephalomyelitis, Autoimmune, Experimental
  • Female
  • Gene Expression
  • Gene Knockdown Techniques
  • Lymphocyte Activation / genetics
  • Lymphocyte Activation / immunology
  • Lymphocyte Count
  • Mice
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt / metabolism
  • RNA Interference
  • Receptors, Interleukin-6 / metabolism
  • STAT3 Transcription Factor / metabolism
  • Signal Transduction
  • T-Lymphocyte Subsets / cytology
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism
  • T-Lymphocytes, Regulatory / cytology*
  • T-Lymphocytes, Regulatory / immunology
  • T-Lymphocytes, Regulatory / metabolism*
  • TOR Serine-Threonine Kinases
  • Th17 Cells / cytology*
  • Th17 Cells / immunology
  • Th17 Cells / metabolism*

Substances

  • Receptors, Interleukin-6
  • STAT3 Transcription Factor
  • Casein Kinase II
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases